News

An IMB graduate will use a Fulbright scholarship to study at Stanford University to address some of the world's biggest challenges - how to end poverty, protect the planet and ensure prosperity for all.

Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

University of Queensland researchers have pioneered a method to integrate data from multiple large-scale studies to assess risk factors such as body mass index (BMI) and cholesterol levels, and their association with diseases including type two diabetes and heart disease.

Gardening is a great way to relax, be one with nature and get your hands dirty. But lurking in that pleasant environment are some nasty bacteria and fungi, with the potential to cause you serious harm. So we need to be vigilant with gardening gloves and other protective wear.

An old drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world’s most dangerous superbugs.

Researchers have new insights into how protective antibodies attack dengue viruses, which could lead to more effective dengue fever vaccines and drug therapies.

The technicians who keep the research machinery running are among recipients of this year’s Institute for Molecular Bioscience (IMB) Impact Awards.

Improving the success rate of heart transplants is among the goals of a University of Queensland researcher, 50 years after the first such surgery was performed in South Africa.

A University of Queensland PhD student will spend 2018 undertaking research and training in sophisticated imaging techniques to better understand how promising Parkinson’s disease drugs enter the brain.

A new and improved version of the 'love hormone' oxytocin has been developed by University of Queensland researchers.

Changes to greatly improve the outcome, treatment and support for women with endometriosis have been the driving force for studies by a University of Queensland researcher.

Cancer biologist Dr Laura Genovesi is the recipient of a 2017 Early Career Fellowship to progress vital research into medulloblastoma, the most common type of malignant childhood brain cancer.

IMB and Cure Brain Cancer Foundation are partnering to overcome the scourge of paediatric brain tumours

Identification of a gene associated with motor neuron disease in people of Chinese ancestry will improve researchers understanding of the condition

Like Spiderman IRL, these clever arachnids pin down their prey with super-fast jets of liquid silk.

A small team in Brisbane are on the global antibiotic discovery map with their collaborative approach to fixing the antibiotic pipeline. They have become a benchmark network for researchers to join the antimicrobial resistance (AMR) field and advancing the AMR agenda in governments worldwide.

Discover how our bright minds and world-leading facilities combine to create solutions for health and environmental problems

IMB's Dr Lachlan Coin and Dr Luregn Schlapbach from the Lady Cilento Children's Hospital are fighting sepsis through developing better diagnostics

The revolution is coming.

Peptides are the new buzzword in medicine. But what's the difference between a peptide and a protein?

Meet the superbug of superbugs